Severe acute respiratory syndrome
MONDO:0005091A viral respiratory infection caused by the SARS coronavirus. It is transmitted through close person-to-person contact. It is manifested with high fever, headache, dry cough and myalgias. It may progress to pneumonia and cause death.
Also known as: SARS, SARS coronavirus caused disease or disorder, SARS coronavirus disease or disorder, SARS coronavirus infectious disease, acute respiratory coronavirus infection
31 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
Brazil tests homegrown mRNA booster against COVID-19
⭐️ VACCINE ⭐️ Not yet recruitingThis early-stage trial tests a new mRNA COVID-19 booster vaccine made by Bio-Manguinhos/Fiocruz. About 90 healthy adults aged 18-59 will receive one of three doses (25, 50, or 100 micrograms) to check safety and immune response. The study is not yet recruiting and will monitor pa…
Phase: PHASE1 • Sponsor: The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 13:06 UTC
-
Could a simple steroid course save lives in severe respiratory infections?
Disease control Not yet recruitingThis study tests whether giving a 7-day course of corticosteroids (like prednisolone) to hospitalized adults with severe respiratory infections and low oxygen levels can reduce deaths and the need for breathing machines. About 3,000 participants will be randomly assigned to recei…
Phase: PHASE4 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New allergy shot under safety spotlight
Symptom relief Not yet recruitingThis study will test the safety of a new biologic drug called stapokibart, given as a shot, in 400 adults with seasonal allergic rhinitis (SAR). Participants are already prescribed the drug by their doctor. The main goal is to track any side effects. This is an open-label study, …
Sponsor: Chengdu Kangnuoxing Biopharma,Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC